| Detected | Trial | Change |
|---|---|---|
| 2026-07-23 | NCT07236411 Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants |
Trial completed |
| 2026-07-23 | NCT07236411 Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants |
date change Primary completion moved earlier: 2026-06 -> 2026-04-16 |
| 2026-07-23 | NCT07236411 Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants |
date change Completion pushed: 2026-06 -> 2026-07-14 |
| 2026-07-23 | NCT07712939 A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With… |
Recruitment opened |
| 2026-07-23 | NCT07408869 A Phase 1 Study of Cizutamig in IgE Mediated Diseases |
critical overall status: Not Yet Recruiting → Withdrawn |
| 2026-07-23 | NCT07408869 A Phase 1 Study of Cizutamig in IgE Mediated Diseases |
critical why stopped: — → Sponsor decision |
| 2026-07-23 | NCT07408869 A Phase 1 Study of Cizutamig in IgE Mediated Diseases |
Enrollment reduced: 20 -> 0 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-20 | NCT07712939 A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT07215650 | Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) | Generalized Myasthenia Gravis | Recruiting |
| NCT07215663 | Clinical Study of Cizutamig in Systemic Lupus Erythematosus | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT07597200 | A Clinical Study of Cizutamig in Thyroid Eye Disease | Thyroid Eye Disease, TED | Recruiting |
| NCT07712939 | A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With… | Healthy Participants Study | Recruiting |
| NCT07052032 | An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis | Rheumatoid Arthritis | Active, Not Recruiting |